The routine brucella agglutination test measures both immunoglobulin M (IgM) and IgG brucella antibody titers; however, only an elevated IgG titer is significant for differentiating active from inactive disease in patients with symptoms lasting 3 or more weeks. The IgG antibody titer can be determined by treating the serum with 2-mercaptoethanol to inactivate the IgM brucella antibodies while leaving the IgG brucella antibodies intact. Dithiothreitol, which also inactivates IgM, was compared with 2-mercaptoethanol for the determination of IgG brucella agglutination titers. The IgM titer can be eliminated by treating the serum specimen with 2-mercaptoethanol (2-ME), which breaks the disulfide bonds and depolymerizes the IgM (5). Depolymerized IgM does not contribute to agglutination; therefore, the titer is due primarily to 2-ME-resistant antibody (IgG). The 2-ME agglutination test is most useful for differentiating active from inactive brucellosis in persons having ill-defined complaints and sterile blood cultures. The presence of 2-ME-resistant (IgG) brucella agglutinins indicates active disease in these types of patients (7) . In addition, the 2-ME agglutination test has been found to be superior to the routine agglutination test for determining the adequacy of antibiotic therapy (3) . A fall in the 2-MEresistant antibody titer indicates a satisfactory response to therapy.
A major objection to the use of the 2-ME test is that 2-ME irritates the eyes and mucous membranes. It also has a very strong and offensive odor. A reagent without these objectionable properties which could be used in place of 2-ME to determine IgG brucella agglutination titers would be an improvement. Dithiothreitol (DTT) depolymerizes IgM but not IgG and does not have the objectionable properties of 2-ME (9). The purpose of our investigation was to find out if DTT could be substituted for 2-ME in determining IgG brucella agglutination titers. An unpaired serum specimen titer of .160 is usually considered to be elevated (positive) and suggestive of a brucella infection (8) .
MATERIALS AND METHODS
Serological tests. The procedure for the routine brucella microagglutination test has been described previously (2) . The same procedure was followed for the 2-ME and DTT tests except that the phosphatebuffered saline used to dilute the serum specimens contained 0.1 M 2-ME or 0.005 M DTT. The final concentrations of the sulfhydryl reagents after the addition of antigen to the tests were 0.05 M 2-ME and 0.0025 M DTT. The 2-ME was obtained from the Eastman Kodak Co., and the DTT was obtained from the Calbiochem-Behring Corp. The tests were done in conical (V)-bottom polystyrene microtitration plates. Reference sera of known high and low titers were included as controls in the routine test, the 2-ME test, and the DTT test. Phenol must not be included in the antigen diluent or in the serum diluent used in the 2-ME and DTT tests because it interferes with the action of 2-ME and DTT.
RESULTS AND DISCUSSION A comparison of the DTT and 2-ME brucella agglutination titers is shown in Table 1 . The same titer was obtained in both tests in 68 of the 105 serum specimens tested. The titer varied by only 1 dilution step in 35 of the remaining 37 specimens. Thus, the DTT and 2-ME agglutination test titers agreed within ±1 dilution step in 98.1% of the 105 specimens tested. This high rate of agreement indicates the DTT can be substituted for 2-ME in the microagglutination test for determining IgG brucella antibody titers. The advantages of using DTT in place of 2-ME are that unlike 2-ME, DTT does not have an offensive odor and does not irritate the eyes or mucous membranes. (7) found that 2-ME-resistant (IgG) brucella agglutinins appear to be a distinguishing feature in differentiating active from inactive disease in patients having ill-defined complaints, sterile blood cultures, and low titers of brucella agglutinins. However, they do not specify what constitutes a significant titer. According to Alton et al. (1) , any positive titer in the 2-ME test should be regarded as indicating infection or should at least lead one to suspect infection. Buchanan and Faber (3) state that a negative (titer of s80) 2-ME test is strong evidence against a diagnosis of brucellosis.
In our laboratory, we consider a DTT-or 2-ME-resistant (IgG) brucella agglutination titer of -20 on an unpaired serum specimen as indicating the absence of active infection and a titer of -160 as suggestive of active infection. A titer of 40 or 80 is reported as inconclusive.
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